Literature DB >> 4200100

L-asparaginase for the treatment of cancer.

K B McCredie, D H Ho, E J Freireich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4200100     DOI: 10.3322/canjclin.23.4.220

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  6 in total

1.  Tumor inhibitory and non-tumor inhibitory L-asparaginases from Pseudomonas geniculata.

Authors:  G B Kitto; G Smith; T Q Thiet; M Mason; L Davidson
Journal:  J Bacteriol       Date:  1979-01       Impact factor: 3.490

Review 2.  Amino acid metabolism in hematologic malignancies and the era of targeted therapy.

Authors:  Yoko Tabe; Philip L Lorenzi; Marina Konopleva
Journal:  Blood       Date:  2019-08-15       Impact factor: 22.113

3.  Studies on efficient production of a novel l-asparaginase by a newly isolated Pseudomonas resinovorans IGS-131 and its heterologous expression in Escherichia coli.

Authors:  Kanti N Mihooliya; Jitender Nandal; Alka Kumari; Sidhanta Nanda; Himanshu Verma; Debendra K Sahoo
Journal:  3 Biotech       Date:  2020-03-02       Impact factor: 2.406

Review 4.  Drug-induced amino acid deprivation as strategy for cancer therapy.

Authors:  Marcus Kwong Lam Fung; Godfrey Chi-Fung Chan
Journal:  J Hematol Oncol       Date:  2017-07-27       Impact factor: 17.388

5.  The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity.

Authors:  Hien Anh Nguyen; Donald L Durden; Arnon Lavie
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

6.  A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.

Authors:  Maristella Maggi; Steven D Mittelman; Jean Hugues Parmentier; Giorgio Colombo; Massimiliano Meli; Jeannette Marie Whitmire; D Scott Merrell; Julian Whitelegge; Claudia Scotti
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.